Panacea Biotec posts consolidated Q4FY21 loss of Rs. 54.14 crore
News

Panacea Biotec posts consolidated Q4FY21 loss of Rs. 54.14 crore

The company reported total income of Rs.634.79 crores during the 12 months period ended March 31, 2021

  • By IPP Bureau | June 03, 2021

Panacea Biotec Ltd has reported total income of Rs.173.17 crores during the period ended March 31, 2021 as compared to Rs.143.65 crores during the period ended December 31, 2020. The company reported total income of Rs.143.34 crores during the period ended March 31, 2020.

The company has posted net loss of Rs. (54.14) crores for the period ended March 31, 2021 as against net loss of Rs. (40.05) crores for the period ended December 31, 2020. It posted net loss of Rs. (69.70) crores for the period ended March 31, 2020.

Panacea Biotec has reported total income of Rs.634.79 crores during the 12 months period ended March 31, 2021 as compared to Rs.573.75 crores during the 12 months period ended March 31, 2020.

The company has posted loss of Rs. (147.65) crores for the 12 months period ended March 31, 2021 as against net loss of Rs.(194.29) crores for the 12 months period ended March 31, 2020.

Upcoming E-conference

Other Related stories

Startup

Digitization